This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Karla Therapeutics

Profile

Karla is a drug development company with platform potential aiming to revolutionize the treatment of mental disorders harnessing the immune system.We have discovered a novel protein "Imood" secreted by T cells and increased in the blood of psychiatric patients. We have data supporting the therapeutic interest of Imood-targeting in multiple psychiatric conditions including mood disorders.We are developing anti-Imood therapeutic antibodies to treat psychiatric diseases.Company creation: 2022